JPMorgan Chase & Co.
JPMorgan Chase & Co. (JPM-PM) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for JPMorgan Chase & Co. (JPM-PM), featuring income statements, balance sheets, and cash flow data.
JPMorgan Chase & Co. (JPM-PM) Income Statement & Financial Overview
Analyze JPMorgan Chase & Co.’s JPM-PM earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $68.91B | $67.007B | $69.67B | $67.83B |
| Cost of Revenue | $26.90B | $26.87B | $30.12B | $28.80B |
| Gross Profit | $42.005B | $40.14B | $39.54B | $39.04B |
| Gross Profit Ratio | $0.61 | $0.60 | $0.57 | $0.58 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $15.73B | $13.80B | $14.07B | $14.17B |
| Operating Expenses | $23.60B | $22.76B | $22.57B | $15.60B |
| Total Costs & Expenses | $50.50B | $49.63B | $52.69B | $44.40B |
| Interest Income | $46.85B | $47.57B | $50.42B | $48.51B |
| Interest Expense | $23.58B | $24.22B | $27.01B | $25.77B |
| Depreciation & Amortization | $2.03B | $1.97B | $1.97B | $2.002B |
| EBITDA | $20.44B | $19.34B | $18.95B | $25.44B |
| EBITDA Ratio | $0.30 | $0.29 | $0.27 | $0.37 |
| Operating Income | $18.41B | $17.38B | $16.98B | $23.43B |
| Operating Income Ratio | $0.27 | $0.26 | $0.24 | $0.35 |
| Other Income/Expenses (Net) | $0.00 | $0.00 | $0.00 | $0.00 |
| Income Before Tax | $18.41B | $17.38B | $16.98B | $23.43B |
| Income Before Tax Ratio | $0.27 | $0.26 | $0.24 | $0.35 |
| Income Tax Expense | $3.77B | $3.37B | $4.08B | $5.29B |
| Net Income | $14.64B | $14.005B | $12.90B | $18.15B |
| Net Income Ratio | $0.21 | $0.21 | $0.19 | $0.27 |
| EPS | $5.08 | $4.82 | $4.38 | $6.13 |
| Diluted EPS | $5.07 | $4.81 | $4.37 | $6.12 |
| Weighted Avg Shares Outstanding | $2.82B | $2.84B | $2.86B | $2.89B |
| Weighted Avg Shares Outstanding (Diluted) | $2.82B | $2.84B | $2.87B | $2.89B |
Over the past four quarters, JPMorgan Chase & Co. demonstrated steady revenue growth, increasing from $67.83B in Q2 2024 to $68.91B in Q1 2025. Operating income reached $18.41B in Q1 2025, maintaining a consistent 27% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $20.44B, reflecting operational efficiency. Net income rose to $14.64B, with EPS at $5.08. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan